We are looking to cooperate with experts to be engaged in R&D expert review of VC projects associated with new developments of pharmaceuticals and technologies in the field of medicine.
Cooperation with external experts is subject to a paid basis.
To participate in R&D expert review activities the experts must obtain accreditation (see below).
The work with experts is based on the following:
Accredited experts subject to the expert review shall assess a scientific value of the VC project under review for potential investment pursuant to standard terms of reference. Impersonal consolidated expert report shall be generated following the results of assessment.
For more information concerning R&D expert review process in RusnanoMedInvest, LLC please go here.
Major expert enrollment criteria:
Accreditation
To join our expert team:
The right to verify information provided is vested in RusnanoMedInvest, LLC.
Please note that filled form is not subject to instant accreditation as an expert.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.